Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|7|631-641

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.7, 2008-03, pp. : 631-641

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches

By  

Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. : 190-206

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 19-26

Bentham Science Publishers

Access to resources Recommend Favorite

The Molecular Genetics of Therapeutic Resistance in Malignant Astrocytomas

By Jennings M.T.   Iyengar S.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 93-99

Adis International

Access to resources Recommend Favorite

JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 816-828

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on Hypocholesterolemic Therapeutic Strategies: An Update

By  

Recent Advances in DNA & Gene Sequences (Formerly Recent Patents on DNA & Gene Sequences), Vol. 9, Iss. 1, 2015-04 ,pp. : 36-44

Bentham Science Publishers

Access to resources Recommend Favorite